Gyre posts updated corporate presentation; no financial or clinical data disclosed

GYRE THERAPEUTICS, INC.

On Aug 26, 2026, Gyre Therapeutics, Inc. posted an updated corporate presentation to its website (Exhibit 99.1, dated August 2026).
Presentation titled 'Building A New Protein Degrader Company For Unmet Medical Needs'; no financial or clinical data appear in the provided text.
The exhibit text is truncated at a disclaimer page; no revenue, EPS, pipeline, or guidance figures are visible.
No forward-looking statements, financial metrics, or clinical updates are included in the excerpt furnished.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.